NEKTAR THERAPEUTICS — Director's Dealing 2019

Dec 17, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEKTAR THERAPEUTICS (NKTR)
CIK: 0000906709
Period of Report: 2019-12-12

Reporting Person: Myriam Curet (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-12-12	Common Stock	A	11700	$0.00	Acquired	11700	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-12-12	Stock Option	$21.79	A	23400	Acquired	2027-12-11	Common Stock (23400)	Direct

Footnotes

F1: This stock award was acquired pursuant to a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive, upon vesting of the unit, one share of the issuer's common stock.

F2: This restricted stock unit award vests over three years in equal annual installments beginning on December 12, 2019.

F3: This stock option vests in equal monthly installments over the three-year period beginning on December 12, 2019.